Pharmacotherapy Specialty Literature Study: Module 2A-C (Cert # L189031)

ACPE Numbers: Various – see listing below
Release Date: 10/10/2018
Expiration Dates: 4/9/2019
Activity Type: Application-based
CE Credits: 15 hours
Activity Fee: $55 (ASHP member); $105 (non-member); $38.50 (Resident Member)

Accreditation for Pharmacists

ASHP is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Target Audience

These recertification activities are intended for board certified pharmacists seeking to update their knowledge and skills in:

  • HIV
    • Preexposure prophylaxis for prevention of HIV infection
    • Providing care for persons with HIV displaced by disasters
    • Initiation of antiretroviral therapy
  • Pediatrics
    • Treatment of asthma
    • Safety concerns with cough and cold medication use
    • Effectiveness of Tetanus, diphtheria and acellular pertussis vaccination
  • Hypertension
    • Guidelines for treating hypertension

Activity Overview

The Literature Study Module is intended for board certified pharmacists in need of recertification credit and is designed based on the content outline developed by the Board of Pharmacy Specialties (BPS). This module consists of 3 online home study activities (see table below). Each activity is designed to assess the learners’ ability to analyze and apply peer-selected contemporary articles to practice and includes a short video for enhanced learning and understanding.

Module 2A: This module focuses on management of patients with HIV. Topics include guidance for non-HIV providers, preexposure prophylaxis and initiation of antiretroviral therapy.

Module 2B: This module focuses on management of pediatric patients.  Topics include the treatment of asthma, use of cough and cold medicines and timing of vaccination to prevent infant pertussis.

Module 2C: This module focuses on the management of hypertension and includes the most recent guideline for high blood pressure in adults.

Learners will be required to review the content and complete the associated online assessments. The learner must be able to correctly answer the questions based upon their interpretation of the content, as well as “baseline specialty specific knowledge and/or easily retrievable information.” For purposes of this Literature Study, “baseline specialty specific knowledge and/or easily retrievable information” is defined as product labeling and well-established standards of practice in the specialty practice.

These activities are part of the ASHP professional development program for BCPS recertification approved by the BPS. 

Recertification Credit*

Board certified pharmacists are eligible to receive up to 15 hours of recertification credit for completing this module. To earn recertification credit, learners must review the activity content and successfully complete the online assessments by the deadline. Only completed assessments will be eligible for credit; no partial or incomplete assessments will be processed. You are allowed only one attempt to successfully complete this assessment.

Learning Activity

ACPE Number

Credit Hours

Specialty

*Assessment Pass Point

Pharmacotherapy Recertification Literature Study Module 2A: HIV

0204-0000-18-907-H02-P

4

BCPS

65%

Pharmacotherapy Recertification Literature Study Module 2B: Pediatrics

0204-0000-18-908-H01-P

6

BCPS

76%

Pharmacotherapy Recertification Literature Study Module 2C: Hypertension

0204-0000-18-909-H01-P

5

BCPS

70%

 

Articles and Learning Objectives 

Module 2A - HIV

This module focuses on management of patients with HIV. Topics include guidance for non-HIV providers, preexposure prophylaxis and initiation of antiretroviral therapy.

U.S. Department of Health and Human Services. Guidance for non-HIV-specialized providers caring for persons with HIV displaced by disasters (such as a hurricane): essential information for managing patients with HIV who are receiving antiretroviral therapy. September 14, 2018.

Learning Objectives:

  • Describe medication management strategies for patients with human immunodeficiency virus (HIV) infection displaced from disaster areas

Centers for Disease Control and Prevention: US Public Health Service: Preexposure prophylaxis for the prevention of HIV infection in the United States—2017 Update: a clinical practice guideline. 

Learning Objectives:

  • Describe the recommended medications, doses, dosing frequency, potential drug interactions, and strategies to improve adherence in the updated 2017 guidelines for preexposure prophylaxis (PrEP) to reduce the risk of acquiring human immunodeficiency virus (HIV) infection
  • Make recommendations for preexposure prophylaxis (PrEP) to reduce the risk of acquiring human immunodeficiency virus (HIV) infection in men who have sex with men (MSM), heterosexually active men or women, or persons who injects drugs (PWID)

INSIGHT START Study Group, Lundgren JD, Babiker AG et al. Initiation of antiretroviral therapy in early asymptomatic HIV Infection. N Engl J Med. 2015; 373:795-807.

Learning Objectives:

  • Explain the rationale, methodology, findings, limitations, and implications of the INSIGHT START study comparing immediate and deferred initiation of antiretroviral therapy (ART) in asymptomatic patients with human immunodeficiency virus (HIV) infection
  • Make a recommendation for the initiation of antiretroviral therapy in asymptomatic patients with human immunodeficiency virus (HIV) infection

Module 2B – Pediatrics

This module focuses on management of pediatric patients.  Topics include the treatment of asthma, use of cough and cold medicines and timing of vaccination to prevent infant pertussis.

Global Initiative for Asthma. Global strategy for asthma management and prevention, updated 2018.

Learning Objectives:

  • Describe the Global Initiative for Asthma recommendations for the diagnosis, assessment, and management of asthma in adults, adolescents, and children age 6 years and older and children 5 years of age and younger
  • Make recommendations for the diagnosis, assessment, and management of asthma taking into consideration patient age, other characteristics, preferences, and practical issues

Green JL, Wang GS, Reynolds KM et al. Safety profile of cough and cold medication use in pediatrics. Pediatrics. 2017; 139: pii: e20163070.

Learning Objectives:

  • Describe the rationale, methodology, and limitations of the study of adverse events associated with cough and cold medication use in pediatric patients less than 12 years of age
  • Compare and contrast the typical patient age and sex, person administering the drug, location of exposure (home vs. other location), and product type associated with reports of adverse events from cough and cold medications in pediatric patients less than 12 years of age
  • Make a recommendation to improve the safety of cough and cold medications in pediatric patients less than 12 years of age

Winter K, Nickell S, Powell M et al. Effectiveness of prenatal versus postpartum tetanus, diphtheria, and acellular pertussis vaccination in preventing infant pertussis. Clin Infect Dis. 2017; 64:3-8.

Learning Objectives:

  • Describe the rationale, methodology, and limitations of the study of prenatal versus postpartum tetanus, diphtheria, and acellular pertussis (Tdap) vaccination for preventing infant pertussis
  • Compare and contrast the effectiveness of tetanus, diphtheria, and acellular pertussis (Tdap) vaccination at various times during pregnancy and postpartum for preventing pertussis in infants less than 8 weeks of age and up to 12 weeks of age
  • Make recommendations for tetanus, diphtheria, and acellular pertussis (Tdap) vaccination in pregnant women

 

Module 2C – Hypertension

This module focuses on the management of hypertension and includes the most recent guideline for high blood pressure in adults.

Whelton PK, Carey RM, Aronow WS et al. 2017 ACC/AHA/AAPA/ABC/ACPM/AGS/APhA/ASH/ ASPC/NMA/PCNA guideline for the prevention, detection, evaluation, and management of high blood pressure in adults: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Hypertension. 2018;71:e13–e115. DOI: 10.1161/ HYP.0000000000000065.

Learning Objectives:

  • Describe the classification, prevalence, etiology, prevention, detection, evaluation, and management of hypertension in adults based on the new guideline from the American College of Cardiology, American Heart Association, and other healthcare professional organizations
  • Make recommendations for the prevention, detection, evaluation, and management of hypertension in adults with hypertension

Faculty

Jason Schafer, Pharm.D., AAHIVP, BCPS, M.P.H.
Associate Professor, Department of Pharmacy Practice
Jefferson College of Pharmacy
Thomas Jefferson University
Philadelphia, Pennsylvania

Bradley McCrory, Pharm.D., BCPS
Clinical Pharmacy Specialist - Pulmonary Medicine
Cincinnati Children's
Cincinnati, Ohio 

Lourdes Cross, Pharm.D., BCACP, CDE
Assistant Professor
Sullivan University College of Pharmacy
Louisville, Kentucky 

Marintha Short, Pharm.D., BCPS-AQ Cardiology
Clinical Pharmacy Specialist - Critical Care/Cardiology
Saint Joseph Hospital
Lexington, Kentucky

Content Matter Experts

Christopher Betz, Pharm.D., BCPS, FKSHP, FASHP
Professor, Department of Clinical and Administrative Sciences
Cardiology Clinical Pharmacy Specialist
Sullivan University College of Pharmacy
Louisville, Kentucky 

Snehal Bhatt, Pharm.D., BCPS
Associate Professor of Pharmacy Practice
Clinical Pharmacist
MCPHS University and Beth Israel Deaconess Medical Center
Boston, Massachusetts 

Douglas Slain, Pharm.D., BCPS, FASHP
Professor
Infectious Diseases Clinical Specialist
West Virginia University
Morgantown, West Virginia

Reviewers

Susan R. Dombrowski, M.S., R.Ph.
Kristi Hofer, Pharm.D.
Sandra Oh Clarke, R.Ph.
Anna Jackson, Pharm.D., BCPS

Field Testers

Alexandra Barnette, Pharm.D., BCPS
Angel Becker, Pharm.D., BCPS
Andrew Beyer, Pharm.D., BCPS
Angela Bosinski, Pharm.D., BCPS
Alexandria Cabrera Yao, Pharm.D., BCPS
Adrian Carlson, Pharm.D., BCPS
Alisa Chamblee, Pharm.D., BCPS
Andrew Clark, Pharm.D., BCPS, CDE, CPP
Aesha Drozdowski, Pharm.D.,BCPS,BCACP
Ahmed Eid, Pharm.D., BCPS
Andrew Good, Pharm.D., MBA, BCPS
Alfredo Guzman, Pharm.D., BCPS
Andrea Hanson, Pharm.D., BCPS
Allison Hein, Pharm.D., BCPS
Alexander Hoffman, Pharm.D., BCPS, CDE
Aamna Khan, Pharm.D., BCPS
Allison Naso, Pharm.D., MBA, BCPS
Angela Paul, Pharm.D., BCPS
Angela Pegram, Pharm.D., BCPS, CDE
Aparna Reddy, Pharm.D., BCPS
Amanda Seddon, Pharm.D., BCOP, BCPS
Anupa Shah, Pharm.D., BCPS, CDE
Amanda Smith, Pharm.D., BCPS, BCPSS
Alan Tan, Pharm.D., BCPS
Amanda Winslow, Pharm.D., BCPS

Disclosures

In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support and the Accreditation Council for Pharmacy Education’s Standards for Commercial Support, ASHP requires that all individuals involved in the development of activity content disclose their relevant financial relationships. A person has a relevant financial relationship if the individual of his or her spouse/partner has a financial relationship (e.g. employee, consultant, research grant recipient, speakers bureau, or stockholder) in any amount occurring the in the last 12 months with a commercial interest whose products or series may be discussed in the educational activity content over which the individual has control. The existence of these relationships is provided for the information of participants and should not be assumed to have an adverse impact on the content.

All faculty and planners for ASHP education activities are qualified and selected by ASHP and required to disclose any relevant financial relationships with commercial interests. ASHP identifies and resolves conflicts of interest prior to an individual’s participation in development of content for an educational activity. Anyone who refuses to disclose relevant financial relationships must be disqualified from any involvement with a continuing pharmacy education activity.

  • Jason Schafer: Research Grant Recipient, Merck
  • All other planners, presenters, and reviewers of this session report no financial relationships relevant to this activity.

Methods and CE Requirements

Activity consists of audio/ video/PDF files, an attestation statement, assessment, and activity evaluation. In order to receive continuing pharmacy education credit, learners must:

  • Complete the attestation statement
  • Review all content
  • Complete and pass the assessment
  • Complete the evaluation
  • Follow the prompts to claim, view, or print the statement of credit within 60 days after completing the activity.

Note: Learner must complete and pass the assessment in order to claim continuing pharmacy education credit.

System Technical Requirements

Courses and learning activities are delivered via your Web browser and Acrobat PDF. For all activities, you should have a basic comfort level using a computer and navigating web sites.

View the minimum technical and system requirements for learning activities.

Development

These activities were developed by ASHP.

To maintain its strict, independent standards for certification, BPS does NOT endorse or provide review information, preparatory courses, or study guides for Board Certification Examinations.